Changing Diabetes in Children
Changing Diabetes® in Children is a public-private partnership established in 2009. The partnership provides comprehensive care for children and young people living with type 1 diabetes in low- and middle-income countries. This includes free life-saving medicine and supplies for persons up to 25 years of age.
SEE ALL PARTNER ORGANIZATIONS
The Changing Diabetes® in Children (CDiC) partnership ensures care and life-saving medicine for children with type 1 diabetes in low- and middle-income countries. It aims at changing the future for children and youth with type 1 diabetes in these countries.
It is estimated that more than 1.2 million young people under the age of 20 have type 1 diabetes and that approximately 184,100 new cases are diagnosed each year. Many of them live in low- and middle-income countries with limited or no access to diabetes care (1). In many low-resource countries, children lack access to insulin, blood glucose monitoring and appropriately trained health professionals. This can lead to poor blood glucose control and subsequent severe health complications and early death (2). Consequently, the Changing Diabetes® in Children partnership was established to bridge critical gaps in access to care for these vulnerable children around the world.
Changing Diabetes® in Children is a public-private partnership launched by Novo Nordisk in 2009. Its global partners are Roche, the International Society for Pediatric and Adolescent Diabetes (ISPAD) and the World Diabetes Foundation (WDF). In each country where the program is active, it is implemented by a group of local partners in close collaboration with national health systems. The program aims to bring all elements of necessary diabetes care closer to the children who need it, while building capacity for the diagnosis and treatment of children with T1D at both community and country levels.
Changing Diabetes® in Children is structured around four components aimed at building a holistic system of care:
- Ensuring comprehensive patient education through equipment and materials
- Strengthening healthcare professional capacity with trainings on T1D diagnosis and treatment
- Bringing care closer to the people who need it by promoting accessible health facilities
- Ensuring access to insulin and supplies through donations and supply chain strengthening.
(1) International Diabetes Federation. IDF Diabetes Atlas, 10 ed. Brussels, Belgium: International Diabetes Federation;2021.
(2) World Health Organization. Global report on diabetes. World Health Organization;2016
“Beyond providing free insulin, Changing Diabetes® in Children has served as a remarkable platform for raising awareness, enhancing the capacity of healthcare professionals, and ensuring holistic care for these young individuals.”
Results and milestones
Since its launch in 2009, Changing Diabetes® in Children has trained more than 24,000 healthcare providers, established 360+ type 1 diabetes clinics, delivered over 3.8M vials, pens, and cartridges of insulin, and reached over 41,000 children in 26 LMICs.
At the launch of its Defeat Diabetes social responsibility strategy in 2019, Novo Nordisk set an ambitious new goal to reach 100,000 vulnerable children and young people living with T1D by 2030.
A decade-long collaboration between Novo Nordisk and the Diabetic Association of Bangladesh (BADAS) has culminated in the government announcing in September 2023 that it will provide free insulin for vulnerable people with type 1 diabetes.
- Eastern Mediterranean
- South-East Asia
- Western Pacific
- Non-communicable diseases
SGDs the partnership contributes to
- 3.8: Achieve universal health coverage
- 3.C: Health workforce
Local hospitals & health centers & patient groups
Local diabetes associations
International Society for Pediatric and Adolescent Diabetes (ISPAD)
World Diabetes Foundation (WDF)
Ministries of Health in programme countries
- Côte d'Ivoire
- Democratic Republic of the Congo
- United Republic of Tanzania
- Viet Nam
- Type 1